Does PEMBROLIZUMAB Cause Hepatitis b? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hepatitis b have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
16
Reports of Hepatitis b with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hepatitis b From PEMBROLIZUMAB?
Of the 16 reports, 4 (25.0%) required hospitalization.
Is Hepatitis b Listed in the Official Label?
Yes, Hepatitis b is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Hepatitis b?
RITUXIMAB (597)
CYCLOPHOSPHAMIDE (578)
LAMIVUDINE (480)
DOXORUBICIN (469)
VINCRISTINE (431)
PREDNISOLONE (371)
TENOFOVIR DISOPROXIL (257)
PREDNISONE (208)
DEXAMETHASONE (173)
ENTECAVIR (166)
Which PEMBROLIZUMAB Alternatives Have Lower Hepatitis b Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G